anterior shoulder dislocation. Unspecified subluxation and dislocation of shoulder joint
Conditions
Interventions
Intervention 1: Intervention group: Remifentanil (1 µg/kg) will be injected intravenously. Remifentanil (0.5 µg/kg) can be repeated three times at the most, and if needed, the drug will be injected a
Sponsors
Rasht University of Medical Sciences
Eligibility
Sex/Gender
All
Age
15 Years to 60 Years
Inclusion criteria
Inclusion criteria: The patients referring to the emergency department of Poursina hospital with acute anterior shoulder dislocation requiring closed reduction
Exclusion criteria
Exclusion criteria: The patients who have been diagnosed with fracture-dislocation of the shoulder joint, except those suffering from Hill-Sachs lesions The patients with decreased GCS and unstable hemodynamic status The patients with immature skeletal system (open epiphysis) or the patients who have undergone surgery previously and have had a fracture in the same shoulder The patients who are allergic to soy and eggs The patients with reduced blood pressure (Systolic Blood Pressure<90 mm Hg) The patients with heart failure The patients over the age of 60 and under the age of 15 years
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Amount of side effects following drug injection such as agitation, nausea, vomiting, and apnea. Timepoint: 1, 5, 10 and 20 minutes after shoulder reduction. Method of measurement: Based on the resident report.;Starting time of reduction after the drug injection. Timepoint: 1, 5, 10 and 20 minutes after shoulder reduction. Method of measurement: Since drug injection until patient sedation in seconds.;Severity of pain. Timepoint: 1, 5, 10 and 20 minutes after shoulder reduction. Method of measurement: The severity of pain before, during, and after joint reduction is measured according to the visual analogue scale based on the patient's statement.;Amount of trouble-freeness in the shoulder joint reduction. Timepoint: 1, 5, 10 and 20 minutes after shoulder reduction. Method of measurement: Based on the resident report.;Stay length in the emergency ward. Timepoint: 1, 5, 10 and 20 minutes after shoulder reduction. Method of measurement: Since the beginning of injection until the end of the recovery (full consciousness) in the patient in minutes.;The need for re-injection of the drug. Timepoint: 1, 5, 10 and 20 minutes after shoulder reduction. Method of measurement: The inadequacy of the sedative and analgesic effects leading to re-inject repeated dose of the drug.;Duration analgesic effect after the drug injection. Timepoint: 1, 5, 10 and 20 minutes after shoulder reduction. Method of measurement: Duration of the sedative and analgesic effects after the injection in minutes. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMarjan Aghajani Nargesi
Rasht University of Medical Sciences
Outcome results
None listed